The nation of Zimbabwe has declined a substantial US healthcare agreement valued at $367m (272 million pounds) spanning five years because of the United States' request for confidential information.
The decision became public after a official document dated December was leaked, which showed President Emmerson Mnangagwa felt the agreement was "lopsided".
An official spokesman later stated that the United States was demanding access to genetic material for research and profit while refused to guarantee the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided over $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has appealed for further talks to reach a deal suitable to both sides so the nation's critical HIV treatment initiative can proceed.
Wider Context
This development follows a similar situation in neighbouring Kenya, where a high court blocked a similar deal with the US after legal challenges were raised about the safety of Kenyans' medical information.
Since resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking government-to-government agreements to boost openness and accountability.
According to statements, Sixteen African countries have to date signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, with no equivalent guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"Effectively, our country would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our citizens should a future disease outbreak arise."
Sovereignty and Global Health
He also noted that the US's withdrawal from the global health body and its push of bilateral deals were disrupting frameworks already set up through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage future pandemics.
"This framework is designed to ensure that when a nation contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome continued discussions with our American counterparts on how future co-operation might be structured in a way that respects the sovereignty and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but recommended that negotiations must proceed since a large portion of the nation's HIV programmes relied on international support.
"Where technical issues exist, including those involving data governance or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," it added.
The situation underscores the continuing debate between receiving vital international aid and safeguarding national sovereignty in an increasingly interconnected world.